Probability and predictors of first treatment contact for anxiety disorders in the United States: Analysis of data from the national epidemiologic survey on alcohol and related conditions (NESARC)

Journal of Clinical Psychiatry

Volumn 74, Issue 11, 2013, Pages 1093-1100

  Iza, Miren ^a   Olfson, Mark ^a   Vermes, Donna ^a   Hoffer, Marcela ^a   Wang, Shuai ^a   Blanco, Carlos ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DSM-IV; FEMALE; GENERALIZED ANXIETY DISORDER; HELP SEEKING BEHAVIOR; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; PANIC; PERSONALITY DISORDER; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SOCIAL PHOBIA; SUBSTANCE ABUSE; SURVIVAL; UNITED STATES;

EID: 84889253976     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08361     Document Type: Article

References (47)

1. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. doi:10.101/archpsyc.62.6. 617 PubMed
2. Heimberg RG. Current status of psychotherapeutic interventions for social phobia. J Clin Psychiatry. 2001;62(suppl 1):36-42. PubMed
3. Telch MJ, Schmidt NB, Jaimez TL, et al. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. J Consult Clin Psychol. 1995;63(5):823-830. doi:10.1037/02-06X.63.5.823 PubMed
4. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62(3):290-298. doi:10.101/archpsyc.62.3.290 PubMed
5. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621-632. doi:10.408/JCP.v69n0415 PubMed
6. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515-2523. doi:10.1056/NEJMsa04326 PubMed
7. Wang PS, Demler O, Olfson M, et al. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry. 2006;163(7):1187-1198. doi:10.176/api.ajp.163.7.187 PubMed
8. Rapaport MH, Clary C, Fayyad R, et al. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162(6):1171-1178. doi:10.176/api.ajp.162.6.171 PubMed
9. Kessler RC, Olfson M, Berglund PA. Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am J Psychiatry. 1998;155(1):62-69. PubMed
10. Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):603-613. doi:10.101/archpsyc.62.6.603 PubMed
11. Neighbors HW, Caldwell C, Williams DR, et al. Race, ethnicity, and the use of services for mental disorders: results from the National Survey of American Life. Arch Gen Psychiatry. 2007;64(4):485-494. doi:10.101/archpsyc.64. 4.485 PubMed
12. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry. 2002;59(1):77-84. doi:10.101/archpsyc.59.1.7 PubMed
13. Mackenzie CS, Reynolds K, Cairney J, et al. Disorder-specific mental health service use for mood and anxiety disorders: associations with age, sex, and psychiatric comorbidity. Depress Anxiety. 2012;29(3):234-242. doi:10.102/da.2091 PubMed
14. Temkin-Greener H, Clark KT. Ethnicity, gender, and utilization of mental health services in a Medicaid population. Soc Sci Med. 1988;26(10):989-996. doi:10.1016/027-9536(8)90216-X PubMed
15. Christiana JM, Gilman SE, Guardino M, et al. Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med. 2000;30(3):693-703. doi:10.1017/S032917902093 PubMed
16. Blanco C, Iza M, Schwartz RP, et al. Probability and predictors of treatmentseeking for prescription opioid use disorders: a national study [published online ahead of print January 7, 2013]. Drug Alcohol Depend. PubMed
17. Olfson M, Liu SM, Grant BF, et al. Influence of comorbid mental disorders on time to seeking treatment for major depressive disorder. Med Care. 2012;50(3):227-232. doi:10.1097/MLR.0b013e318241eb5e PubMed
18. Grant B, Moore T, Shepard J, et al. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
19. Ruan WJ, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92(1-3):27-36. doi:10.1016/j.drugalcdep.207.06.01 PubMed
20. Grant B, Kaplan K, Moore T, et al. 2004-2005 Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions: Source and Accuracy Statement. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2007.
21. Grant BF, Dawson DA, Hasin DS. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001.
22. Grant BF, Dawson DA, Hasin DS. The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004.
23. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051-1066. doi:10.1038/mp.208.41 PubMed
24. Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(4):361-368. doi:10.101/archpsyc.61.4.361 PubMed
25. Huppert JD, Strunk DR, Ledley DR, et al. Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. Depress Anxiety. 2008;25(5):441-448. doi:10.102/da.20349 PubMed
26. Schneier FR, Blanco C, Antia SX, et al. The social anxiety spectrum. Psychiatr Clin North Am. 2002;25(4):757-774. doi:10.1016/S0193-953X(02)018-7 PubMed
27. Olfson M, Kessler RC, Berglund PA, et al. Psychiatric disorder onset and first treatment contact in the United States and Ontario. Am J Psychiatry. 1998;155(10):1415-1422. PubMed
28. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415-424. doi:10.101/archpsyc.63.4.415 PubMed
29. Comer JS, Blanco C, Hasin DS, et al. Health-related quality of life across the anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2011;72(1):43-50. doi:10.408/JCP.09m05094blu PubMed
30. Antony MM, Roth D, Swinson RP, et al. Illness intrusiveness in individuals with panic disorder, obsessive-compulsive disorder, or social phobia. J Nerv Ment Dis. 1998;186(5):311-315. doi:10.1097/05053-198050-08 PubMed
31. Safren SA, Heimberg RG, Brown EJ, et al. Quality of life in social phobia. Depress Anxiety. 1996/1997;4(3):126-133. doi:10.102/(SICI)1520-6394(196) 4:3<126:AID-DA5>3.0.CO;2-E PubMed
32. Buckner JD, Heimberg RG, Schneier FR, et al. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2012;124(1-2):128-134. doi:10.1016/j.drugalcdep.201.12.023 PubMed
33. Schneier FR, Foose TE, Hasin DS, et al. Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2010;40(6):977-988. doi:10.1017/S032917091231 PubMed
34. Buckner JD, Schmidt NB, Lang AR, et al. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res. 2008;42(3):230-239. doi:10.1016/j.jpsychires.207.01.02 PubMed
35. Hedman E, Andersson E, Ljosson B, et al. Cost-effectiveness of Internetbased cognitive behavior therapy vs cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial. Behav Res Ther. 2011;49(11):729-736. doi:10.1016/j.brat.201.07.09 PubMed
36. Hedman E, Andersson G, Ljosson B, et al. Internet-based cognitive behavior therapy vs cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. PLoS ONE. 2011;6(3):e18001. doi:10.1371/journal.pone.01801 PubMed
37. Thompson A, Hunt C, Issakidis C. Why wait? reasons for delay and prompts to seek help for mental health problems in an Australian clinical sample. Soc Psychiatry Psychiatr Epidemiol. 2004;39(10):810-817. PubMed
38. Stein DJ, Scott K, Haro Abad JM, et al. Early childhood adversity and later hypertension: data from the World Mental Health Survey. Ann Clin Psychiatry. 2010;22(1):19-28. PubMed
39. Scott KM, Von Korff M, Alonso J, et al. Childhood adversity, early-onset depressive/anxiety disorders, and adult-onset asthma. Psychosom Med. 2008;70(9):1035-1043. doi:10.1097/PSY.0b013e318187a2fb PubMed
40. Have M, Oldehinkel A, Vollebergh W, et al. Does educational background explain inequalities in care service use for mental health problems in the Dutch general population? Acta Psychiatr Scand. 2003;107(3):178-187. doi:10.1034/j.160-047.203.074.x PubMed
41. Tijhuis MA, Peters L, Foets M. An orientation toward help-seeking for emotional problems. Soc Sci Med. 1990;31(9):989-995. doi:10.1016/027-9536(90) 90108-5 PubMed
42. Keyes KM, Martins SS, Blanco C, et al. Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry. 2010;167(8):969-976. doi:10.176/api.ajp.209.0908161 PubMed
43. Khan SS, Secades-Villa R, Okuda M, et al. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend. 2013;130(1-3):101-108. doi:10.1016/j.drugalcdep.2012.10.015 PubMed
44. Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep. 2007;9(5):374-380. doi:10.107/s1920-07-048-0 PubMed
45. Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv. 2003;54(3):363-369. doi:10.176/api.ps.54.3.363 PubMed
46. Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv. 2005;56(8):954-959. doi:10.176/api.ps.56.8.954 PubMed
47. Keyser DJ, Watkins KE, Vilamovska AM, et al. Focus on alcohol and drug abuse: improving service delivery for individuals with co-occurring disorders: new perspectives on the quadrant model. Psychiatr Serv. 2008;59(11):1251-1253.